Beef­ing up its res­pi­ra­to­ry pipeline, Glax­o­SmithK­line bags J&J drug in $230M deal

Glax­o­SmithK­line has found a new ther­a­py to add to its big pipeline of res­pi­ra­to­ry drugs. The UK-based phar­ma group in-li­censed J&J’s CN­TO 7160, an an­ti …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.